InVivoMAb anti-mouse CD28 - 1 mg and 2 more items

The University of Nebraska Medical Center (UNMC), a state institution located in Omaha, Nebraska, awarded a purchase order to Bio X Cell, a vendor based in Lebanon, New Hampshire, on May 21, 2026. The contract, valued at $3,305.40, covers the delivery of three monoclonal antibody products for research purposes with a completion date of May 28, 2026. The line items include two units of InVivoMAb anti-mouse CD28 (1 mg) at $124.60 per unit, one unit of InVivoMAb anti-mouse CD8 (25 mg) at $1,528.10, and one unit of InVivoMAb rat IgG2b isotype control (25 mg) at $1,528.10. These immunological reagents are commonly utilized in laboratory research applications.

Delivery is designated to UNMC General Supply at 601 South Saddle Creek Road in Omaha, Nebraska, under Free on Board (FOB) destination terms. The purchase order is governed by the University of Nebraska's Standard Terms of Purchase, with payment terms specified as net upon receipt of goods and invoice. The purchasing authority acted on behalf of the Board of Regents of the University of Nebraska, establishing this as a state-level institutional procurement within Nebraska.